These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


246 related items for PubMed ID: 11522281

  • 1. Serum cortisol/cortisone ratio after Synacthen stimulation.
    Vogeser M, Zachoval R, Jacob K.
    Clin Biochem; 2001 Jul; 34(5):421-5. PubMed ID: 11522281
    [Abstract] [Full Text] [Related]

  • 2. Increased ratio of serum cortisol to cortisone in acute-phase response.
    Vogeser M, Zachoval R, Felbinger TW, Jacob K.
    Horm Res; 2002 Jul; 58(4):172-5. PubMed ID: 12324714
    [Abstract] [Full Text] [Related]

  • 3. Enhanced 11beta-hydroxysteroid dehydrogenase type 1 activity in stress adaptation in the guinea pig.
    Quinkler M, Troeger H, Eigendorff E, Maser-Gluth C, Stiglic A, Oelkers W, Bähr V, Diederich S.
    J Endocrinol; 2003 Feb; 176(2):185-92. PubMed ID: 12553867
    [Abstract] [Full Text] [Related]

  • 4. Assessing systemic 11beta-hydroxysteroid dehydrogenase with serum cortisone/cortisol ratios in healthy subjects and patients with diabetes mellitus and chronic renal failure.
    Homma M, Tanaka A, Hino K, Takamura H, Hirano T, Oka K, Kanazawa M, Miwa T, Notoya Y, Niitsuma T, Hayashi T.
    Metabolism; 2001 Jul; 50(7):801-4. PubMed ID: 11436185
    [Abstract] [Full Text] [Related]

  • 5. Effect of glucocorticoid excess on the cortisol/cortisone ratio.
    Dötsch J, Dörr HG, Stalla GK, Sippell WG.
    Steroids; 2001 Nov; 66(11):817-20. PubMed ID: 11576621
    [Abstract] [Full Text] [Related]

  • 6. Dialyzable free cortisol after stimulation with Synacthen.
    Vogeser M, Briegel J, Zachoval R.
    Clin Biochem; 2002 Oct; 35(7):539-43. PubMed ID: 12493582
    [Abstract] [Full Text] [Related]

  • 7. Growth hormone, insulin-like growth factor-I and the cortisol-cortisone shuttle.
    Stewart PM, Toogood AA, Tomlinson JW.
    Horm Res; 2001 Oct; 56 Suppl 1():1-6. PubMed ID: 11786677
    [Abstract] [Full Text] [Related]

  • 8. 11beta-hydroxysteroid dehydrogenase expression and activity in the human adrenal cortex.
    Mazzocchi G, Rossi GP, Neri G, Malendowicz LK, Albertin G, Nussdorfer GG.
    FASEB J; 1998 Nov; 12(14):1533-9. PubMed ID: 9806762
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Simultaneous measurements of cortisol and cortisone in urine and hair for the assessment of 11β-hydroxysteroid dehydrogenase activity among methadone maintenance treatment patients with LC-ESI-MS/MS.
    Chen Z, Li J, Xu G, Yang J, Zhang J, Deng H.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Oct 15; 969():77-84. PubMed ID: 25151333
    [Abstract] [Full Text] [Related]

  • 12. Cortisol-secreting adrenal adenomas express 11beta-hydroxysteroid dehydrogenase type-2 gene yet possess low 11beta-HSD2 activity.
    Mazzocchi G, Aragona F, Malendowicz LK, Gottardo L, Nussdorfer GG.
    J Investig Med; 2001 Mar 15; 49(2):191-4. PubMed ID: 11288760
    [Abstract] [Full Text] [Related]

  • 13. Mineralocorticoid excess and inhibition of 11 beta-hydroxysteroid dehydrogenase in patients with ectopic ACTH syndrome.
    Walker BR, Campbell JC, Fraser R, Stewart PM, Edwards CR.
    Clin Endocrinol (Oxf); 1992 Dec 15; 37(6):483-92. PubMed ID: 1337504
    [Abstract] [Full Text] [Related]

  • 14. Cortisol metabolism and the role of 11beta-hydroxysteroid dehydrogenase.
    Tomlinson JW, Stewart PM.
    Best Pract Res Clin Endocrinol Metab; 2001 Mar 15; 15(1):61-78. PubMed ID: 11469811
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A rapid method for the measurement of the oxoreductase activity of 11beta-hydroxysteroid dehydrogenase in granulosa-lutein cells from patients undergoing in-vitro fertilization.
    Knaggs P, Lambert A, Proudfoot F, Nickson I, Hooper MA, Lenton E, Robertson WR.
    Mol Hum Reprod; 1998 Feb 15; 4(2):147-51. PubMed ID: 9542972
    [Abstract] [Full Text] [Related]

  • 17. Tissue-specific Cushing's syndrome, 11beta-hydroxysteroid dehydrogenases and the redefinition of corticosteroid hormone action.
    Stewart PM.
    Eur J Endocrinol; 2003 Sep 15; 149(3):163-8. PubMed ID: 12943516
    [Abstract] [Full Text] [Related]

  • 18. Human kidney 11 beta-hydroxysteroid dehydrogenase: regulation by adrenocorticotropin?
    Diederich S, Quinkler M, Miller K, Heilmann P, Schoneshofer M, Oelkers W.
    Eur J Endocrinol; 1996 Mar 15; 134(3):301-7. PubMed ID: 8616526
    [Abstract] [Full Text] [Related]

  • 19. Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11beta-hydroxysteroid dehydrogenase type 1 activity.
    Rask E, Walker BR, Söderberg S, Livingstone DE, Eliasson M, Johnson O, Andrew R, Olsson T.
    J Clin Endocrinol Metab; 2002 Jul 15; 87(7):3330-6. PubMed ID: 12107245
    [Abstract] [Full Text] [Related]

  • 20. Growth hormone replacement inhibits renal and hepatic 11 beta-hydroxysteroid dehydrogenases in ACTH-deficient patients.
    Walker BR, Andrew R, MacLeod KM, Padfield PL.
    Clin Endocrinol (Oxf); 1998 Aug 15; 49(2):257-63. PubMed ID: 9828916
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.